Clearing the Confusion: TAR [MINI BOOK]
TAR (technology-assisted review) can save a significant amount of time and money. It is statistically sound and has been validated in dozens of court cases, yet adoption of the tool is still slow.
[Read More]TAR (technology-assisted review) can save a significant amount of time and money. It is statistically sound and has been validated in dozens of court cases, yet adoption of the tool is still slow.
[Read More]As 2015 comes to a close, we pause to review a few of our top white papers of the year. The papers below range in topics from successful budgeting practices to how to
[Read More]Prior to Judge Peck’s recent buzzworthy TAR opinion, TAR’s presence was also noteworthy in two other cases: Bridgestone Americas, Inc. v. IBM Corporation and Connecticut General Life Insurance v. Health Diagnostic Laboratory, Inc.
[Read More]College playoff basketball isn’t the only hot topic this month — so, too, is the matter of using technology-assisted review (TAR). U.S. Magistrate Judge Andrew Peck’s recent order in Rio Tinto Plc v.
[Read More]For the first time in China, tech companies surpassed state firms as the country’s most valuable brands. According to Reuters, the annual rankings, which are based on an analysis of revenue and consumer
[Read More]More than a decade ago, U.S. law firms were placing their Mandarin-speaking attorneys in offices in China. Now, as China’s investment in this country has ballooned into the billions, firms are keeping more of
[Read More]Happy New Year! Let’s get right to it: What are your resolutions for 2015? While going to the gym and eating healthier may be on your personal list, what about your professional one?
[Read More]U.S. Magistrate Judge John Facciola, who has served on the U.S. District Court for the District of Columbia since 1997, spoke to a class of law students at the University of Florida Levin College
[Read More]Takeda Pharmaceuticals faces multiple lawsuits alleging that it was aware of and willfully concealed a link between one of its most popular drugs, Actos, and increased risk for bladder cancer. This case is
[Read More]We'll keep your email safe. No spam, we promise!